182 related articles for article (PubMed ID: 26239079)
1. Variability in hepatic expression of organic anion transporter 7/SLC22A9, a novel pravastatin uptake transporter: impact of genetic and regulatory factors.
Emami Riedmaier A; Burk O; van Eijck BA; Schaeffeler E; Klein K; Fehr S; Biskup S; Müller S; Winter S; Zanger UM; Schwab M; Nies AT
Pharmacogenomics J; 2016 Aug; 16(4):341-51. PubMed ID: 26239079
[TBL] [Abstract][Full Text] [Related]
2. The Membrane Transporter OAT7 (SLC22A9) Is Not a Susceptibility Factor for Osteoporosis in Europeans.
Nies AT; Weiss S; Schaeffeler E; Hannemann A; Völker U; Wallaschofski H; Schwab M
Front Endocrinol (Lausanne); 2020; 11():532. PubMed ID: 33013684
[TBL] [Abstract][Full Text] [Related]
3. Quantification of Hepatic Organic Anion Transport Proteins OAT2 and OAT7 in Human Liver Tissue and Primary Hepatocytes.
Vildhede A; Kimoto E; Rodrigues AD; Varma MVS
Mol Pharm; 2018 Aug; 15(8):3227-3235. PubMed ID: 29906129
[TBL] [Abstract][Full Text] [Related]
4. Novel liver-specific organic anion transporter OAT7 that operates the exchange of sulfate conjugates for short chain fatty acid butyrate.
Shin HJ; Anzai N; Enomoto A; He X; Kim DK; Endou H; Kanai Y
Hepatology; 2007 Apr; 45(4):1046-55. PubMed ID: 17393504
[TBL] [Abstract][Full Text] [Related]
5. The human organic anion transporter genes OAT5 and OAT7 are transactivated by hepatocyte nuclear factor-1α (HNF-1α).
Klein K; Jüngst C; Mwinyi J; Stieger B; Krempler F; Patsch W; Eloranta JJ; Kullak-Ublick GA
Mol Pharmacol; 2010 Dec; 78(6):1079-87. PubMed ID: 20829431
[TBL] [Abstract][Full Text] [Related]
6. Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data.
Kunze A; Huwyler J; Camenisch G; Poller B
Drug Metab Dispos; 2014 Sep; 42(9):1514-21. PubMed ID: 24989890
[TBL] [Abstract][Full Text] [Related]
7. In vitro studies with two human organic anion transporters: OAT2 and OAT7.
Mathialagan S; Costales C; Tylaska L; Kimoto E; Vildhede A; Johnson J; Johnson N; Sarashina T; Hashizume K; Isringhausen CD; Vermeer LMM; Wolff AR; Rodrigues AD
Xenobiotica; 2018 Oct; 48(10):1037-1049. PubMed ID: 28945155
[TBL] [Abstract][Full Text] [Related]
8. The influence of macrolide antibiotics on the uptake of organic anions and drugs mediated by OATP1B1 and OATP1B3.
Seithel A; Eberl S; Singer K; Auge D; Heinkele G; Wolf NB; Dörje F; Fromm MF; König J
Drug Metab Dispos; 2007 May; 35(5):779-86. PubMed ID: 17296622
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of organic anion transporting polypeptide 1B1 and 1B3 humanized mice as a translational model to study the pharmacokinetics of statins.
Salphati L; Chu X; Chen L; Prasad B; Dallas S; Evers R; Mamaril-Fishman D; Geier EG; Kehler J; Kunta J; Mezler M; Laplanche L; Pang J; Rode A; Soars MG; Unadkat JD; van Waterschoot RA; Yabut J; Schinkel AH; Scheer N
Drug Metab Dispos; 2014 Aug; 42(8):1301-13. PubMed ID: 24855184
[TBL] [Abstract][Full Text] [Related]
10. Functional involvement of rat organic anion transporter 3 (rOat3; Slc22a8) in the renal uptake of organic anions.
Hasegawa M; Kusuhara H; Sugiyama D; Ito K; Ueda S; Endou H; Sugiyama Y
J Pharmacol Exp Ther; 2002 Mar; 300(3):746-53. PubMed ID: 11861777
[TBL] [Abstract][Full Text] [Related]
11. Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3.
Noé J; Portmann R; Brun ME; Funk C
Drug Metab Dispos; 2007 Aug; 35(8):1308-14. PubMed ID: 17470528
[TBL] [Abstract][Full Text] [Related]
12. Targeted disruption of murine organic anion-transporting polypeptide 1b2 (Oatp1b2/Slco1b2) significantly alters disposition of prototypical drug substrates pravastatin and rifampin.
Zaher H; Meyer zu Schwabedissen HE; Tirona RG; Cox ML; Obert LA; Agrawal N; Palandra J; Stock JL; Kim RB; Ware JA
Mol Pharmacol; 2008 Aug; 74(2):320-9. PubMed ID: 18413659
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics.
Nishizato Y; Ieiri I; Suzuki H; Kimura M; Kawabata K; Hirota T; Takane H; Irie S; Kusuhara H; Urasaki Y; Urae A; Higuchi S; Otsubo K; Sugiyama Y
Clin Pharmacol Ther; 2003 Jun; 73(6):554-65. PubMed ID: 12811365
[TBL] [Abstract][Full Text] [Related]
14. Identification, expression, and functional characterization of full-length and splice variants of murine organic anion transporting polypeptide 1b2.
Meyer Zu Schwabedissen HE; Ware JA; Tirona RG; Kim RB
Mol Pharm; 2009; 6(6):1790-7. PubMed ID: 19400585
[TBL] [Abstract][Full Text] [Related]
15. Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1- and OATP1B3-mediated drug transport.
Kindla J; Müller F; Mieth M; Fromm MF; König J
Drug Metab Dispos; 2011 Jun; 39(6):1047-53. PubMed ID: 21389119
[TBL] [Abstract][Full Text] [Related]
16. Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Karlgren M; Vildhede A; Norinder U; Wisniewski JR; Kimoto E; Lai Y; Haglund U; Artursson P
J Med Chem; 2012 May; 55(10):4740-63. PubMed ID: 22541068
[TBL] [Abstract][Full Text] [Related]
17. Characterization of organic anion transporting polypeptide (OATP) expression and its functional contribution to the uptake of substrates in human hepatocytes.
Kimoto E; Yoshida K; Balogh LM; Bi YA; Maeda K; El-Kattan A; Sugiyama Y; Lai Y
Mol Pharm; 2012 Dec; 9(12):3535-42. PubMed ID: 23082789
[TBL] [Abstract][Full Text] [Related]
18. Explaining Ethnic Variability of Transporter Substrate Pharmacokinetics in Healthy Asian and Caucasian Subjects with Allele Frequencies of OATP1B1 and BCRP: A Mechanistic Modeling Analysis.
Li R; Barton HA
Clin Pharmacokinet; 2018 Apr; 57(4):491-503. PubMed ID: 28653144
[TBL] [Abstract][Full Text] [Related]
19. A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters.
Hsiang B; Zhu Y; Wang Z; Wu Y; Sasseville V; Yang WP; Kirchgessner TG
J Biol Chem; 1999 Dec; 274(52):37161-8. PubMed ID: 10601278
[TBL] [Abstract][Full Text] [Related]
20. Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1.
Bachmakov I; Glaeser H; Fromm MF; König J
Diabetes; 2008 Jun; 57(6):1463-9. PubMed ID: 18314419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
